|1.||Di Bari, M: 1 article (11/2012)|
|2.||Calogero, A: 1 article (11/2012)|
|3.||Tata, A M: 1 article (11/2012)|
|4.||Ferretti, M: 1 article (11/2012)|
|5.||Ponti, D: 1 article (11/2012)|
|6.||Fabbiano, C: 1 article (11/2012)|
|7.||Yan, Fu-Lin: 1 article (06/2010)|
|8.||Wang, Da-Xin: 1 article (06/2010)|
|9.||Liu, Wen-Yan: 1 article (06/2010)|
|10.||Li, Hui: 1 article (06/2010)|
06/25/1995 - "Furthermore, gallamine treatment that completely blocked bradycardia evoked by ACh administration reduced vagally-mediated bradycardia. "
12/01/1985 - "Gallamine antagonized the bradycardia, whereas no influence was found on the bladder contraction. "
06/01/1976 - "Gallamine gave additional safety in the prevention of bradycardia. "
06/01/1995 - "To assess the relative efficacy of a pacing esophageal stethoscope and intermittent boluses (40 mg) of gallamine in correcting sinus bradycardia (SB) during coronary artery surgery. "
06/01/1995 - "Transesophageal atrial pacing (TAP) for sinus bradycardia during coronary artery bypass grafting: comparison of TAP to intermittent bolus gallamine."
|2.||Renal Insufficiency (Renal Failure)
08/01/1981 - "3 Comparison of the model-independent pharmacokinetic parameters for gallamine between these patients and a group of normal patients revealed that the elimination phase half-life (T and one-half beta) was significantly prolonged in renal failure with a marked reduction in the plasma clearance of gallamine. "
08/01/1981 - "7. The results suggest that gallamine is not to be preferred to other nondepolarizing muscle relaxants in patients with renal failure."
08/01/1981 - "4 Gallamine had larger apparent volumes of distribution in the presence of renal failure than those found in normal patients. "
10/01/1972 - "Hazards of gallamine administration in patients with renal failure."
11/01/1970 - "Administration of gallamine in the presence of renal failure--reversal of neuromuscular blockade by peritoneal dialysis."
|3.||Amnesia (Dissociative Amnesia)
|4.||Anaphylaxis (Anaphylactic Shock)
02/01/2002 - "Gallamine was diagnosed the responsible drug and our patient developed anaphylaxis during intradermal testing (IDT) with this compound. "
06/01/1986 - "Two cases are described in which patients developed acute anaphylactic reactions to precurarising doses of gallamine. "
06/01/1986 - "Anaphylaxis to precurarising doses of gallamine triethiodide."
08/01/1978 - "Anaphylactic reactions to gallamine."
02/01/1978 - "All reported cases of anaphylaxis to gallamine have occurred in women, and all the confirmed cases in Australasia. "
01/01/1977 - "Furthermore the higher doses of gallamine caused an unacceptably high frequency of patients with tachycardia and signs and symptoms of partial curarization."
10/01/1965 - "[Studies on the causes of gallamine tachycardia and its antagonistic modification by beta adrenolytics]."
01/01/1987 - "It is suggested that this phenomenon might play some role in tachycardia observed during surgical anaesthesia when gallamine or pancuronium have been administered."
03/01/1998 - "The high affinities of gallamine and pancuronium for the M2 muscarinic receptor are consistent with a mechanism of M2 receptor blockade in relaxant-induced tachycardia."
07/01/1981 - "ORG NC45, a neuromuscular blocking agent not producing tachycardia, was examined first, to establish the kinetics of the anatagonism it produces, and second, to test the hypothesis that the tachycardia seen with pancuronium and gallamine reflects an action on vagal postganglionic nerve endings. "
|2.||Succinylcholine (Suxamethonium Chloride)
|4.||Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
|5.||4- diphenylacetoxy- 1,1- dimethylpiperidinium
|7.||Muscarinic M1 Receptor
|9.||Tubocurarine (Tubocurarine Chloride)
|3.||Artificial Respiration (Mechanical Ventilation)